Delivery Order SPE2DB25D3306-SPE2DB25FUCZD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,830 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 ml on-body injectors. The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by October 14, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,830 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 180 mg/1.2 mL on-body injector units. This firm fixed-price, non-set-aside delivery order was awarded on September 9, 2025, with an ultimate completion date of September 30, 2025. The pharmaceutical product will be delivered to a location in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectors. This firm fixed-price, competitively awarded contract was issued on July 22, 2025, with an ultimate completion date of August 12, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $11,830 on September 8, 2025, for the supply of SKYRIZI 180 mg/1.2 ml on-body injectors. This firm fixed-price delivery order, with completion expected by September 29, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 ml on-body injector devices. This firm fixed price delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 180 mg/1.2 ml on-body injectors. This firm fixed price contract, awarded on October 31, 2025, with an ultimate completion date of November 24, 2025, represents a non-competitive, non-set-aside procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, serving the federal government's...
- The Defense Logistics Agency awarded a $23,660 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 mL on-body injectors on October 16, 2025, with completion targeted for November 6, 2025. This firm fixed-price, competitively awarded contract involves pharmaceutical supply to support military and federal healthcare operations. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $11,830 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injector units. The contract, awarded on September 5, 2025, with an ultimate completion date of September 26, 2025, represents a non-set-aside, competitively awarded procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectors valued at $11,830. This competitively awarded, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of September 16, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $11.83K delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of SKYRIZI 360 mg/2.4 mL on-body injector units. The contract is unset-aside and competitively awarded on a firm fixed-price basis, with performance originating from the company's Conshohocken, Pennsylvania facility and scheduled completion by October 8, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCZDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,830 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 180 mg/1.2 mL on-body injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation, with a completion date of October 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 through December 2026. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp has demonstrated consistent capability in fulfilling federal medical procurement requirements through competitive awards and serves as a critical vendor for the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 9/17/25 |